| Health / Medical Topics |
c-Met Inhibitor AMG 337
An orally bioavailable inhibitor of the proto-oncogene c-Met with potential antineoplastic activity. c-Met inhibitor AMG 337 selectively binds to c-Met, thereby disrupting c-Met signal transduction pathways. This may induce cell death in tumor cells overexpressing c-Met protein or expressing constitutively activated c-Met protein. c-Met protein, the product of the proto-oncogene c-Met, is a receptor tyrosine kinase also known as hepatocyte growth factor receptor (HGFR); this protein is overexpressed or mutated in many tumor cell types and plays key roles in tumor cell proliferation, survival, invasion, and metastasis, and tumor angiogenesis. (NCI Thesaurus)
YOU MAY ALSO LIKE
A selective small-molecule inhibitor of the proto-oncogene c-Met with potential antineoplastic activity. c-Met inhibitor AMG 208 inhibits the ligand-dependent and ligand-independent activation…
A protein found on the surface of many different types of cells. It binds to a substance called stem cell factor (SCF),…
A substance that has been studied in the treatment of cancer and is being studied in the treatment of rheumatoid arthritis and…
An oligonucleotide targeting the c-fos gene which decreases c-fos target mRNA and protein expression, thereby inducing differentiation and inhibiting cell proliferation. …
Describes cancer cells that have too much of a protein called HER2 on their surface. In normal cells, HER2 helps to control…
A protein involved in normal cell growth. It is found on some types of cancer cells, including breast and ovarian. Cancer…
